Hidefumi Kinoshita - Concepedia

Author

Hidefumi Kinoshita

Also Known As

H Kinoshita, H. Kinoshita, H., Kinoshita, HIDEFUMI KINOSHITA, Hidefumi Kinoshita, Kenji Yoshida, Kim, Kinoshita, Hidefumi, Masaaki Yanishi, Tadashi Matsuda

348

Publications

4.7K

Citations

H-Index

140

Concepts

All Affiliations

Kansai Medical University Kyoto University Tohoku University Kagawa University Akita University

About

Hidefumi Kinoshita is an author at Kansai Medical University specializing in medicine, urology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	52	2.4K
2	Health Sciences	10	10	321
3	Engineering	2	2	50
4	Public Health	2	2	27
5	Arts	1	1	15

Hidefumi Kinoshita

115

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, The Lancet Oncology First-line TherapyUrologyChemotherapy Versus ChemotherapyGenitourinary CancerMedicine	2021	627
Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. David F. Jarrard, Hidefumi Kinoshita, Yan Shi, PubMed Androgen ReceptorEpigenetic ChangeGeneticsDna MethylationProstate Cancer Cells	1998	236
Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Hidefumi Kinoshita, Y. Shi, Carol Sandefur, PubMed Androgen ReceptorEpigenetic ChangeGeneticsDna MethylationEpigenetics	2000	188
Formation of 8‐hydroxy‐2′‐deoxyguanosine and 4‐hydroxy‐2‐nonenal‐modified proteins in human renal‐cell carcinoma Keisei Okamoto, Shinya Toyokuni, Kôji Uchida, International Journal of Cancer	1994	179
Antiandrogen Bicalutamide Promotes Tumor Growth in a Novel Androgen-Dependent Prostate Cancer Xenograft Model Derived from a Bicalutamide-Treated Patient Toru Yoshida, Hidefumi Kinoshita, Takehiko Segawa, Cancer Research	2005	176
p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. David F. Jarrard, Somdatta Sarkar, Yan Shi, PubMed UrologyCell RegulationMedicineP16/prb Pathway AlterationsP16/prb Pathway	1999	157
Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population Takahiro Inoue, Takehiko Segawa, Taizou Shiraishi, Urology Androgen ReceptorUrologyGenitourinary CancerMedicineP53 Expression	2005	81
Characteristics and outcomes of ureteroscopic treatment in 2650 patients with impacted ureteral stones Jaap D. Legemate, Nienke J. Wijnstok, Tadashi Matsuda, World Journal of Urology	2017	81
Ureteral Wall Thickness as a Preoperative Indicator of Impacted Stones in Patients With Ureteral Stones Undergoing Ureteroscopic Lithotripsy Takashi Yoshida, Takaaki Inoue, Naoto Omura, Urology Urogenital RadiologyUreteral Wall ThicknessUrologyPreoperative IndicatorImpacted Stones	2017	81
Increased risk of prostate cancer associated with <i>AA</i> genotype of <i>cyclin D1</i> gene <i>A</i>870<i>G</i> polymorphism Lizhong Wang, Tomonori Habuchi, Kenji Mitsumori, International Journal of Cancer	2002	80

Page 1